Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4151
Outdoor Holding Co
POWW
$265M
| $115K | ﹤0.01% |
51,289
-132,546
| -72% | -$297K |
2026 Q1
2 quarters
|
|
4152
CALL
Goodyear
GT
$1.16B
| $115K | ﹤0.01% |
23,200
-32,500
| -58% | -$203K |
2025 Q2
5 quarters
|
|
4153
ICL Group
ICL
$5.92B
| $115K | ﹤0.01% |
22,918
+6,839
| +43% | +$36.6K |
2025 Q4
3 quarters
|
|
4154
Spero Therapeutics
SPRO
$58.2M
| $114K | ﹤0.01% |
+94,478
| New | +$128K |
2026 Q3
0 quarters
|
|
4155
MNTN Inc
MNTN
$378M
| $113K | ﹤0.01% |
+11,130
| New | +$124K |
2026 Q3
0 quarters
|
|
4156
Entrada Therapeutics
TRDA
$202M
| $113K | ﹤0.01% |
+17,775
| New | +$123K |
2026 Q3
0 quarters
|
|
4157
ZoomInfo Technologies
GTM
$968M
| $113K | ﹤0.01% |
29,726
-93,902
| -76% | -$341K |
2026 Q1
2 quarters
|
|
4158
NextDecade
NEXT
$1.75B
| $113K | ﹤0.01% |
17,728
-190,892
| -92% | -$1.37M |
2024 Q3
8 quarters
|
|
4159
Hain Celestial
HAIN
$13M
| $112K | ﹤0.01% |
229,438
+190,274
| +486% | +$113K |
2026 Q2
1 quarter
|
|
4160
BRC Inc
BRCC
$241M
| $112K | ﹤0.01% |
12,340
+5,046
| +69% | +$49.3K |
2026 Q1
2 quarters
|
|
4161
Motorcar Parts of America
MPAA
$146M
| $112K | ﹤0.01% |
+10,636
| New | +$133K |
2026 Q3
0 quarters
|
|
4162
Ocugen
OCGN
$296M
| $111K | ﹤0.01% |
107,712
-28,999
| -21% | -$36.9K |
2025 Q3
4 quarters
|
|
4163
CALL
Keel Infrastructure Corp
KEEL
$1.2B
| $110K | ﹤0.01% |
31,100
+19,100
| +159% | +$73.4K |
2026 Q2
1 quarter
|
|
4164
Galectin Therapeutics
GALT
$317M
| $109K | ﹤0.01% |
+28,193
| New | +$109K |
2026 Q3
0 quarters
|
|
4165
Apyx Medical
APYX
$122M
| $109K | ﹤0.01% |
44,601
+12,457
| +39% | +$43.5K |
2026 Q2
1 quarter
|
|
4166
Genelux
GNLX
$86M
| $107K | ﹤0.01% |
+42,346
| New | +$115K |
2026 Q3
0 quarters
|
|
4167
CALL
JetBlue
JBLU
$1.44B
| $105K | ﹤0.01% |
24,900
+4,500
| +22% | +$23.3K |
2026 Q2
1 quarter
|
|
4168
CALL
Fermi Inc
FRMI
$1.32B
| $105K | ﹤0.01% |
+25,000
| New | +$148K |
2026 Q3
0 quarters
|
|
4169
Eikon Therapeutics
EIKN
$327M
| $105K | ﹤0.01% |
+13,026
| New | +$131K |
2026 Q3
0 quarters
|
|
4170
N-able
NABL
$848M
| $104K | ﹤0.01% |
+25,283
| New | +$104K |
2026 Q3
0 quarters
|
|
4171
Cerus
CERS
$392M
| $103K | ﹤0.01% |
43,208
-66,188
| -61% | -$182K |
2025 Q4
3 quarters
|
|
4172
Ramaco Resources Class B
METCB
$262M
| $103K | ﹤0.01% |
+22,876
| New | +$148K |
2026 Q3
0 quarters
|
|
4173
Pony AI Inc
PONY
$1.93B
| $102K | ﹤0.01% |
15,598
-46,380
| -75% | -$338K |
2025 Q3
4 quarters
|
|
4174
Oxford Lane Capital
OXLC
$493M
| $102K | ﹤0.01% |
+11,267
| New | +$104K |
2026 Q3
0 quarters
|
|
4175
SKYX Platforms
SKYX
$111M
| $101K | ﹤0.01% |
87,728
-19,432
| -18% | -$23.5K |
2026 Q1
2 quarters
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.